TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs6906021
log Bayes Factor = 280.702
Chromosome 6   position 32,626,311  (GRCh37) Explore rs6906021 on Ensembl!
Variant rs6906021 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
1.000 0.000 0.000
E05.9 Thyrotoxicosis, unspecified
1.000 0.000 0.000
E05.0 Thyrotoxicosis with diffuse goitre
1.000 0.000 0.000
J45.9 Asthma, unspecified
1.000 0.000 0.000
K90.0 Coeliac disease
1.000 0.000 0.000
E05 Thyrotoxicosis [hyperthyroidism]
1.000 0.000 0.000
E03 Other hypothyroidism
1.000 0.000 0.000
E00-E07 Disorders of thyroid gland
0.999 0.001 0.000
E83.1 Disorders of iron metabolism
0.000 0.001 0.999
D00-D09 In situ neoplasms
0.997 0.003 0.000
D06 Carcinoma in situ of cervix uteri
0.997 0.003 0.000
D06.9 Cervix, unspecified
0.996 0.004 0.000
D07 Carcinoma in situ of other and unspecified genital organs
0.994 0.006 0.000
D07.1 Vulva
0.993 0.007 0.000
D04 Carcinoma in situ of skin
0.982 0.018 0.000
K90 Intestinal malabsorption
0.977 0.023 0.000
K90.9 Intestinal malabsorption, unspecified
0.971 0.029 0.000
D64.9 Anaemia, unspecified
0.967 0.033 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.040 0.960
T42.4 Benzodiazepines
0.000 0.052 0.948
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.055 0.945
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.063 0.937
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.068 0.932
T43.2 Other and unspecified antidepressants
0.000 0.089 0.911
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.091 0.909
D04.7 Skin of lower limb, including hip
0.897 0.103 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.103 0.897
L72.1 Trichilemmal cyst
0.000 0.109 0.891
D04.5 Skin of trunk
0.884 0.116 0.000
D03 Melanoma in situ
0.883 0.117 0.000
D07.4 Penis
0.873 0.127 0.000
L72 Follicular cysts of skin and subcutaneous tissue
0.000 0.134 0.866
L40.5 Arthropathic psoriasis
0.000 0.141 0.859
D04.9 Skin, unspecified
0.857 0.143 0.000
L60-L75 Disorders of skin appendages
0.000 0.147 0.852
T42.0 Hydantoin derivatives
0.000 0.153 0.847
L40 Psoriasis
0.001 0.158 0.840
L71 Rosacea
0.000 0.159 0.841
D04.4 Skin of scalp and neck
0.835 0.165 0.000
E07 Other disorders of thyroid
0.833 0.167 0.000
D09 Carcinoma in situ of other and unspecified sites
0.831 0.169 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.173 0.827
L40.9 Psoriasis, unspecified
0.000 0.177 0.823
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.817 0.183 0.000
D01 Carcinoma in situ of other and unspecified digestive organs
0.812 0.188 0.000
T42.1 Iminostilbenes
0.000 0.189 0.811
L71.1 Rhinophyma
0.000 0.190 0.810
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.192 0.808
D03.2 Melanoma in situ of ear and external auricular canal
0.802 0.198 0.000
E03.8 Other specified hypothyroidism
0.793 0.207 0.000
E05.8 Other thyrotoxicosis
0.792 0.208 0.000
D07.2 Vagina
0.787 0.213 0.000
L40-L45 Papulosquamous disorders
0.019 0.216 0.766
Chapter XII Diseases of the skin and subcutaneous tissue
0.029 0.218 0.754
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.218 0.781
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.222 0.778
D06.1 Exocervix
0.777 0.223 0.000
L70 Acne
0.000 0.227 0.773
L71.9 Rosacea, unspecified
0.000 0.228 0.772
G35 Multiple sclerosis
0.000 0.233 0.767
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.240 0.759
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.757 0.243 0.000
D02 Carcinoma in situ of middle ear and respiratory system
0.754 0.245 0.000
T50.4 Drugs affecting uric acid metabolism
0.000 0.246 0.754
D03.5 Melanoma in situ of trunk
0.753 0.247 0.000
E07.9 Disorder of thyroid, unspecified
0.753 0.247 0.000
D04.3 Skin of other and unspecified parts of face
0.737 0.263 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.264 0.736
L72.0 Epidermal cyst
0.000 0.269 0.731
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.269 0.731
T50.8 Diagnostic agents
0.000 0.270 0.730
D00 Carcinoma in situ of oral cavity, oesophagus and stomach
0.724 0.276 0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.723 0.277 0.000
E05.5 Thyroid crisis or storm
0.717 0.283 0.000
E05.4 Thyrotoxicosis factitia
0.717 0.283 0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.717 0.283 0.000
E03.5 Myxoedema coma
0.717 0.283 0.000
E03.4 Atrophy of thyroid (acquired)
0.717 0.283 0.000
E03.3 Postinfectious hypothyroidism
0.717 0.283 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.716 0.283 0.000
E00 Congenital iodine-deficiency syndrome
0.716 0.283 0.000
D06.7 Other parts of cervix
0.714 0.285 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.287 0.713
D07.6 Other and unspecified male genital organs
0.713 0.287 0.000
D07.3 Other and unspecified female genital organs
0.713 0.287 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.287 0.713
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.289 0.711
D09.1 Other and unspecified urinary organs
0.709 0.291 0.000
D04.2 Skin of ear and external auricular canal
0.706 0.294 0.000
D04.8 Skin of other sites
0.704 0.296 0.000
D04.0 Skin of lip
0.704 0.296 0.000
K90.3 Pancreatic steatorrhoea
0.701 0.299 0.000
K90.2 Blind loop syndrome, not elsewhere classified
0.701 0.299 0.000
K90.1 Tropical sprue
0.701 0.299 0.000
E03.1 Congenital hypothyroidism without goitre
0.699 0.301 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.302 0.698
D06.0 Endocervix
0.696 0.303 0.000
K90.8 Other intestinal malabsorption
0.692 0.308 0.000
D07.0 Endometrium
0.690 0.310 0.000
L70.0 Acne vulgaris
0.000 0.311 0.689
T42.3 Barbiturates
0.000 0.311 0.689
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.312 0.688
T42.2 Succinimides and oxazolidinediones
0.000 0.312 0.688
D03.8 Melanoma in situ of other sites
0.688 0.312 0.000
E06 Thyroiditis
0.687 0.313 0.000
D03.0 Melanoma in situ of lip
0.687 0.313 0.000
E02 Subclinical iodine-deficiency hypothyroidism
0.675 0.325 0.000
L40.8 Other psoriasis
0.001 0.329 0.671
T36 Poisoning by systemic antibiotics
0.000 0.329 0.670
T43.9 Psychotropic drug, unspecified
0.000 0.332 0.668
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.332 0.668
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.335 0.665
E03.0 Congenital hypothyroidism with diffuse goitre
0.665 0.335 0.000
D04.1 Skin of eyelid, including canthus
0.663 0.337 0.000
T39.0 Salicylates
0.000 0.339 0.661
D01.3 Anus and anal canal
0.659 0.340 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.345 0.655
D01.0 Colon
0.655 0.345 0.000
T50.7 Analeptics and opioid receptor antagonists
0.000 0.348 0.651
T50.5 Appetite depressants
0.000 0.348 0.651
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.348 0.651
T50.1 Loop [high-ceiling] diuretics
0.000 0.348 0.651
T50.0 Mineralocorticoids and their antagonists
0.000 0.348 0.651
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.350 0.650
D09.7 Carcinoma in situ of other specified sites
0.648 0.352 0.000
D03.7 Melanoma in situ of lower limb, including hip
0.642 0.358 0.000
D03.9 Melanoma in situ, unspecified
0.633 0.367 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.367 0.633
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.373 0.627
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.373 0.627
L70.9 Acne, unspecified
0.000 0.376 0.624
L63 Alopecia areata
0.000 0.377 0.622
L72.2 Steatocystoma multiplex
0.000 0.379 0.621
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.379 0.620
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.384 0.616
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.385 0.615
L75 Apocrine sweat disorders
0.000 0.389 0.611
L74 Eccrine sweat disorders
0.000 0.389 0.611
L67 Hair colour and hair shaft abnormalities
0.000 0.389 0.611
L64 Androgenic alopecia
0.000 0.389 0.611
L62 Nail disorders in diseases classified elsewhere
0.000 0.389 0.611
L68 Hypertrichosis
0.000 0.390 0.609
D03.6 Melanoma in situ of upper limb, including shoulder
0.609 0.391 0.000
D02.2 Bronchus and lung
0.606 0.394 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.395 0.605
D64 Other anaemias
0.604 0.396 0.000
L40.2 Acrodermatitis continua
0.001 0.396 0.602
L71.8 Other rosacea
0.000 0.397 0.603
L71.0 Perioral dermatitis
0.000 0.397 0.603
L00-L08 Infections of the skin and subcutaneous tissue
0.001 0.397 0.602
D09.9 Carcinoma in situ, unspecified
0.601 0.399 0.000
L72.8 Other follicular cysts of skin and subcutaneous tissue
0.000 0.402 0.598
E07.1 Dyshormogenetic goitre
0.597 0.403 0.000
E07.0 Hypersecretion of calcitonin
0.597 0.403 0.000
D09.3 Thyroid and other endocrine glands
0.596 0.404 0.000
D09.2 Eye
0.596 0.404 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.416 0.584
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.582 0.418 0.000
D01.9 Digestive organ, unspecified
0.582 0.418 0.000
D01.7 Other specified digestive organs
0.582 0.418 0.000
D01.5 Liver, gallbladder and bile ducts
0.582 0.418 0.000
D01.4 Other and unspecified parts of intestine
0.582 0.418 0.000
D01.1 Rectosigmoid junction
0.582 0.418 0.000
L40.1 Generalised pustular psoriasis
0.001 0.420 0.579
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.421 0.579
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.421 0.579
T46.7 Peripheral vasodilators
0.000 0.421 0.579
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.421 0.579
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.429 0.571
E06.3 Autoimmune thyroiditis
0.565 0.435 0.000
L41 Parapsoriasis
0.013 0.438 0.549
L45 Papulosquamous disorders in diseases classified elsewhere
0.013 0.438 0.549
D03.4 Melanoma in situ of scalp and neck
0.562 0.438 0.000
D03.1 Melanoma in situ of eyelid, including canthus
0.562 0.438 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.439 0.561
T43.6 Psychostimulants with abuse potential
0.000 0.443 0.557
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.444 0.556
L02 Cutaneous abscess, furuncle and carbuncle
0.000 0.445 0.555
L70.8 Other acne
0.000 0.446 0.554
L70.5 Acne excoriee des jeunes filles
0.000 0.446 0.554
L70.4 Infantile acne
0.000 0.446 0.554
L70.3 Acne tropica
0.000 0.446 0.554
L70.2 Acne varioliformis
0.000 0.446 0.554
L70.1 Acne conglobata
0.000 0.446 0.554
D04.6 Skin of upper limb, including shoulder
0.552 0.447 0.000
T48.5 Anti-common-cold drugs
0.000 0.450 0.549
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.451 0.549
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.455 0.545
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.455 0.545
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.455 0.545
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.455 0.545
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.455 0.545
T44.0 Anticholinesterase agents
0.000 0.455 0.545
L66 Cicatricial alopecia [scarring hair loss]
0.000 0.459 0.541
D02.4 Respiratory system, unspecified
0.541 0.459 0.000
D02.3 Other parts of respiratory system
0.541 0.459 0.000
D02.1 Trachea
0.541 0.459 0.000
T46.1 Calcium-channel blockers
0.000 0.464 0.536
D09.0 Bladder
0.533 0.467 0.000
D00.1 Oesophagus
0.530 0.470 0.000
L05 Pilonidal cyst
0.000 0.471 0.529
L02.4 Cutaneous abscess, furuncle and carbuncle of limb
0.000 0.477 0.523
L65 Other nonscarring hair loss
0.000 0.479 0.521
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue
0.018 0.479 0.504
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.479 0.521
L40.4 Guttate psoriasis
0.001 0.479 0.519
Chapter IV Endocrine, nutritional and metabolic diseases
0.520 0.480 0.000
D00.2 Stomach
0.519 0.481 0.000
D01.2 Rectum
0.519 0.481 0.000
D00.0 Lip, oral cavity and pharynx
0.519 0.481 0.000
L40.3 Pustulosis palmaris et plantaris
0.001 0.484 0.515
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.514 0.486 0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.514 0.486 0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.514 0.486 0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.514 0.486 0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.514 0.486 0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.514 0.486 0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.514 0.486 0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.514 0.486 0.000
T39.4 Antirheumatics, not elsewhere classified
0.000 0.488 0.511
T39.2 Pyrazolone derivatives
0.000 0.488 0.511
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.490 0.510
T48.4 Expectorants
0.000 0.490 0.510
T48.3 Antitussives
0.000 0.490 0.510
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.490 0.510
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.490 0.510
T48.0 Oxytocic drugs
0.000 0.490 0.510
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.493 0.507
L44 Other papulosquamous disorders
0.015 0.494 0.491
D02.0 Larynx
0.504 0.496 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.498 0.501
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.499 0.500
T37.5 Antiviral drugs
0.000 0.499 0.500
T37.4 Anthelminthics
0.000 0.499 0.500
T37.3 Other antiprotozoal drugs
0.000 0.499 0.500
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.499 0.500
T37.1 Antimycobacterial drugs
0.000 0.499 0.500
T37.0 Sulphonamides
0.000 0.499 0.500
E06.5 Other chronic thyroiditis
0.499 0.501 0.000
T47.0 Histamine H(2)-receptor antagonists
0.000 0.501 0.499
T36.3 Macrolides
0.000 0.502 0.498
E10-E14 Diabetes mellitus
0.497 0.503 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.504 0.496
L42 Pityriasis rosea
0.013 0.504 0.482
E06.4 Drug-induced thyroiditis
0.493 0.507 0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.493 0.507 0.000
E06.0 Acute thyroiditis
0.493 0.507 0.000
E07.8 Other specified disorders of thyroid
0.484 0.516 0.000
T47.2 Stimulant laxatives
0.000 0.517 0.483
L01 Impetigo
0.000 0.517 0.483
T36.9 Systemic antibiotic, unspecified
0.000 0.519 0.481
T36.8 Other systemic antibiotics
0.000 0.519 0.481
T36.7 Antifungal antibiotics, systemically used
0.000 0.519 0.481
T36.6 Rifamycins
0.000 0.519 0.481
T36.5 Aminoglycosides
0.000 0.519 0.481
T36.4 Tetracyclines
0.000 0.519 0.481
T36.2 Chloramphenicol group
0.000 0.519 0.481
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.519 0.481
T38.1 Thyroid hormones and substitutes
0.000 0.525 0.475
E20-E35 Disorders of other endocrine glands
0.475 0.525 0.000
L02.8 Cutaneous abscess, furuncle and carbuncle of other sites
0.000 0.527 0.473
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.534 0.466
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.534 0.466
T47.7 Emetics
0.000 0.534 0.466
T47.5 Digestants
0.000 0.534 0.466
T47.3 Saline and osmotic laxatives
0.000 0.534 0.466
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.464 0.536 0.000
L63.9 Alopecia areata, unspecified
0.000 0.542 0.457
G35-G37 Demyelinating diseases of the central nervous system
0.001 0.543 0.456
E10 Insulin-dependent diabetes mellitus
0.457 0.543 0.000
E10.9 Without complications
0.457 0.543 0.000
J45 Asthma
0.456 0.544 0.000
E14 Unspecified diabetes mellitus
0.454 0.546 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.546 0.454
T36.0 Penicillins
0.000 0.546 0.453
D64.8 Other specified anaemias
0.452 0.548 0.000
L20-L30 Dermatitis and eczema
0.002 0.550 0.448
T41.5 Therapeutic gases
0.000 0.550 0.450
T41.4 Anaesthetic, unspecified
0.000 0.550 0.450
T41.3 Local anaesthetics
0.000 0.550 0.450
T41.1 Intravenous anaesthetics
0.000 0.550 0.450
T41.0 Inhaled anaesthetics
0.000 0.550 0.450
L60 Nail disorders
0.000 0.551 0.449
L63.8 Other alopecia areata
0.000 0.553 0.446
L63.2 Ophiasis
0.000 0.553 0.446
L63.1 Alopecia universalis
0.000 0.553 0.446
L63.0 Alopecia (capitis) totalis
0.000 0.553 0.446
T47.4 Other laxatives
0.000 0.554 0.446
T49.9 Topical agent, unspecified
0.000 0.555 0.445
T49.8 Other topical agents
0.000 0.555 0.445
T49.7 Dental drugs, topically applied
0.000 0.555 0.445
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.555 0.445
T49.5 Ophthalmological drugs and preparations
0.000 0.555 0.445
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.555 0.445
T49.3 Emollients, demulcents and protectants
0.000 0.555 0.445
T49.2 Local astringents and local detergents
0.000 0.555 0.445
T49.1 Antipruritics
0.000 0.555 0.445
L05.0 Pilonidal cyst with abscess
0.000 0.557 0.443
E21.0 Primary hyperparathyroidism
0.440 0.560 0.000
L62.8 Nail disorders in other diseases classified elsewhere
0.000 0.561 0.438
L62.0 Clubbed nail pachydermoperiostosis
0.000 0.561 0.438
L64.9 Androgenic alopecia, unspecified
0.000 0.561 0.438
L64.8 Other androgenic alopecia
0.000 0.561 0.438
L64.0 Drug-induced androgenic alopecia
0.000 0.561 0.438
L67.9 Hair colour and hair shaft abnormality, unspecified
0.000 0.561 0.438
L67.8 Other hair colour and hair shaft abnormalities
0.000 0.561 0.438
L67.1 Variations in hair colour
0.000 0.561 0.438
L67.0 Trichorrhexis nodosa
0.000 0.561 0.438
L74.9 Eccrine sweat disorder, unspecified
0.000 0.561 0.438
L74.8 Other eccrine sweat disorders
0.000 0.561 0.438
L74.4 Anhidrosis
0.000 0.561 0.438
L74.3 Miliaria, unspecified
0.000 0.561 0.438
L74.2 Miliaria profunda
0.000 0.561 0.438
L74.1 Miliaria crystallina
0.000 0.561 0.438
L74.0 Miliaria rubra
0.000 0.561 0.438
L75.9 Apocrine sweat disorder, unspecified
0.000 0.561 0.438
L75.8 Other apocrine sweat disorders
0.000 0.561 0.438
L75.2 Apocrine miliaria
0.000 0.561 0.438
L75.1 Chromhidrosis
0.000 0.561 0.438
L75.0 Bromhidrosis
0.000 0.561 0.438
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.562 0.438
L68.9 Hypertrichosis, unspecified
0.000 0.563 0.437
L68.8 Other hypertrichosis
0.000 0.563 0.437
L68.3 Polytrichia
0.000 0.563 0.437
L68.2 Localised hypertrichosis
0.000 0.563 0.437
L68.1 Acquired hypertrichosis lanuginosa
0.000 0.563 0.437
L05.9 Pilonidal cyst without abscess
0.000 0.563 0.437
E06.1 Subacute thyroiditis
0.436 0.564 0.000
L04 Acute lymphadenitis
0.000 0.564 0.436
L68.0 Hirsutism
0.000 0.565 0.435
E24 Cushing's syndrome
0.434 0.566 0.000
D64.4 Congenital dyserythropoietic anaemia
0.433 0.567 0.000
D64.3 Other sideroblastic anaemias
0.433 0.567 0.000
D64.2 Secondary sideroblastic anaemia due to drugs and toxins
0.433 0.567 0.000
D64.1 Secondary sideroblastic anaemia due to disease
0.433 0.567 0.000
D64.0 Hereditary sideroblastic anaemia
0.433 0.567 0.000
L00 Staphylococcal scalded skin syndrome
0.001 0.568 0.432
E13 Other specified diabetes mellitus
0.432 0.568 0.000
T47.6 Antidiarrhoeal drugs
0.000 0.569 0.430
D03.3 Melanoma in situ of other and unspecified parts of face
0.428 0.572 0.000
L57 Skin changes due to chronic exposure to nonionising radiation
0.004 0.575 0.420
E14.3 With ophthalmic complications
0.423 0.577 0.000
N40 Hyperplasia of prostate
0.000 0.578 0.422
T38.9 Other and unspecified hormone antagonists
0.000 0.581 0.419
T38.7 Androgens and anabolic congeners
0.000 0.581 0.419
T38.4 Oral contraceptives
0.000 0.581 0.419
T38.2 Antithyroid drugs
0.000 0.581 0.419
T38.0 Glucocorticoids and synthetic analogues
0.000 0.581 0.419
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.416 0.584 0.000
L02.0 Cutaneous abscess, furuncle and carbuncle of face
0.000 0.585 0.415
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.587 0.413
L40.0 Psoriasis vulgaris
0.001 0.587 0.412
L57.8 Other skin changes due to chronic exposure to nonionising radiation
0.000 0.590 0.410
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock
0.000 0.593 0.407
L21 Seborrhoeic dermatitis
0.001 0.596 0.403
L41.9 Parapsoriasis, unspecified
0.010 0.597 0.394
L41.8 Other parapsoriasis
0.010 0.597 0.394
L41.5 Retiform parapsoriasis
0.010 0.597 0.394
L41.4 Large plaque parapsoriasis
0.010 0.597 0.394
L41.3 Small plaque parapsoriasis
0.010 0.597 0.394
L41.2 Lymphomatoid papulosis
0.010 0.597 0.394
L41.1 Pityriasis lichenoides chronica
0.010 0.597 0.394
L41.0 Pityriasis lichenoides et varioliformis acuta
0.010 0.597 0.394
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.402 0.598 0.000
E06.9 Thyroiditis, unspecified
0.401 0.599 0.000
T41.2 Other and unspecified general anaesthetics
0.000 0.601 0.399
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.601 0.399
L01.0 Impetigo [any organism] [any site]
0.000 0.602 0.397
L02.1 Cutaneous abscess, furuncle and carbuncle of neck
0.000 0.603 0.397
G37 Other demyelinating diseases of central nervous system
0.000 0.604 0.396
E27 Other disorders of adrenal gland
0.396 0.604 0.000
E21.3 Hyperparathyroidism, unspecified
0.393 0.607 0.000
T40.6 Other and unspecified narcotics
0.000 0.607 0.393
T38.5 Other oestrogens and progestogens
0.000 0.610 0.389
L66.8 Other cicatricial alopecia
0.000 0.612 0.388
L66.4 Folliculitis ulerythematosa reticulata
0.000 0.612 0.388
L66.3 Perifolliculitis capitis abscedens
0.000 0.612 0.388
L66.2 Folliculitis decalvans
0.000 0.612 0.388
L66.0 Pseudopelade
0.000 0.612 0.388
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.612 0.388
L60.8 Other nail disorders
0.000 0.615 0.385
E13.9 Without complications
0.383 0.617 0.000
L20 Atopic dermatitis
0.001 0.618 0.381
E14.4 With neurological complications
0.380 0.620 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.620 0.379
E27.1 Primary adrenocortical insufficiency
0.379 0.621 0.000
L65.8 Other specified nonscarring hair loss
0.000 0.626 0.374
L65.2 Alopecia mucinosa
0.000 0.626 0.374
L65.1 Anagen effluvium
0.000 0.626 0.374
L65.0 Telogen effluvium
0.000 0.626 0.374
L58 Radiodermatitis
0.013 0.626 0.361
L55 Sunburn
0.013 0.626 0.361
L66.9 Cicatricial alopecia, unspecified
0.000 0.628 0.371
L21.9 Seborrhoeic dermatitis, unspecified
0.000 0.629 0.371
E24.0 Pituitary-dependent Cushing's disease
0.371 0.629 0.000
E24.9 Cushing's syndrome, unspecified
0.365 0.635 0.000
E31 Polyglandular dysfunction
0.363 0.637 0.000
L44.9 Papulosquamous disorder, unspecified
0.011 0.637 0.352
L44.8 Other specified papulosquamous disorders
0.011 0.637 0.352
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.011 0.637 0.352
L44.3 Lichen ruber moniliformis
0.011 0.637 0.352
L44.2 Lichen striatus
0.011 0.637 0.352
L44.1 Lichen nitidus
0.011 0.637 0.352
E10.0 With coma
0.362 0.638 0.000
T45.0 Antiallergic and antiemetic drugs
0.000 0.640 0.360
E20 Hypoparathyroidism
0.358 0.642 0.000
E14.1 With ketoacidosis
0.357 0.643 0.000
G37.9 Demyelinating disease of central nervous system, unspecified
0.000 0.643 0.357
E14.8 With unspecified complications
0.357 0.643 0.000
E14.2 Withrenal complications
0.356 0.644 0.000
E12 Malnutrition-related diabetes mellitus
0.356 0.644 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.644 0.356
T45.8 Other primarily systemic and haematological agents
0.000 0.644 0.356
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.644 0.356
T45.6 Fibrinolysis-affecting drugs
0.000 0.644 0.356
T45.4 Iron and its compounds
0.000 0.644 0.356
T45.3 Enzymes, not elsewhere classified
0.000 0.644 0.356
L50-L54 Urticaria and erythema
0.019 0.648 0.333
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk
0.000 0.650 0.350
E21.4 Other specified disorders of parathyroid gland
0.349 0.651 0.000
L01.1 Impetiginisation of other dermatoses
0.000 0.653 0.346
J45.1 Nonallergic asthma
0.346 0.654 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.656 0.344
E24.2 Drug-induced Cushing's syndrome
0.342 0.658 0.000
T45.5 Anticoagulants
0.000 0.658 0.342
E16 Other disorders of pancreatic internal secretion
0.341 0.659 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.340 0.659 0.000
E32 Diseases of thymus
0.340 0.659 0.000
E30 Disorders of puberty, not elsewhere classified
0.340 0.659 0.000
L23 Allergic contact dermatitis
0.001 0.660 0.339
L66.1 Lichen planopilaris
0.001 0.660 0.339
E21.2 Other hyperparathyroidism
0.337 0.663 0.000
T40.5 Cocaine
0.000 0.663 0.337
L59 Other disorders of skin and subcutaneous tissue related to radiation
0.013 0.664 0.323
L60.1 Onycholysis
0.000 0.666 0.334
J45.0 Predominantly allergic asthma
0.333 0.667 0.000
E14.5 With peripheral circulatory complications
0.332 0.668 0.000
L25 Unspecified contact dermatitis
0.001 0.672 0.327
E10.6 With other specified complications
0.326 0.674 0.000
E14.7 With multiple complications
0.326 0.674 0.000
E14.0 With coma
0.326 0.674 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.674 0.325
T40.8 Lysergide [LSD]
0.000 0.674 0.325
T40.7 Cannabis (derivatives)
0.000 0.674 0.325
T40.3 Methadone
0.000 0.674 0.325
T40.1 Heroin
0.000 0.674 0.325
T40.0 Opium
0.000 0.674 0.325
E25 Adrenogenital disorders
0.325 0.675 0.000
L20.9 Atopic dermatitis, unspecified
0.000 0.677 0.323
E10.4 With neurological complications
0.323 0.677 0.000
G36 Other acute disseminated demyelination
0.001 0.677 0.322
L24 Irritant contact dermatitis
0.001 0.677 0.321
L26 Exfoliative dermatitis
0.001 0.677 0.321
L22 Diaper [napkin] dermatitis
0.001 0.677 0.321
L60.5 Yellow nail syndrome
0.000 0.678 0.322
L60.4 Beau's lines
0.000 0.678 0.322
L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified
0.000 0.678 0.322
T45.2 Vitamins, not elsewhere classified
0.000 0.678 0.321
L60.3 Nail dystrophy
0.000 0.679 0.321
E27.3 Drug-induced adrenocortical insufficiency
0.321 0.679 0.000
J45.8 Mixed asthma
0.319 0.681 0.000
L04.0 Acute lymphadenitis of face, head and neck
0.000 0.682 0.318
E10.7 With multiple complications
0.317 0.683 0.000
E13.3 With ophthalmic complications
0.314 0.685 0.000
L04.2 Acute lymphadenitis of upper limb
0.000 0.687 0.313
L04.8 Acute lymphadenitis of other sites
0.000 0.687 0.312
L04.3 Acute lymphadenitis of lower limb
0.000 0.687 0.312
L04.1 Acute lymphadenitis of trunk
0.000 0.687 0.312
D60-D64 Aplastic and other anaemias
0.312 0.687 0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.311 0.688 0.000
E24.3 Ectopic ACTH syndrome
0.311 0.688 0.000
E24.1 Nelson's syndrome
0.311 0.688 0.000
L04.9 Acute lymphadenitis, unspecified
0.000 0.690 0.310
E13.8 With unspecified complications
0.310 0.690 0.000
E13.7 With multiple complications
0.310 0.690 0.000
E13.6 With other specified complications
0.310 0.690 0.000
E13.5 With peripheral circulatory complications
0.310 0.690 0.000
E13.4 With neurological complications
0.310 0.690 0.000
E13.2 With renal complications
0.310 0.690 0.000
E13.1 With ketoacidosis
0.310 0.690 0.000
E13.0 With coma
0.310 0.690 0.000
L44.0 Pityriasis rubra pilaris
0.012 0.693 0.295
E27.2 Addisonian crisis
0.307 0.693 0.000
L57.5 Actinic granuloma
0.003 0.694 0.303
E40-E46 Malnutrition
0.306 0.694 0.000
L57.3 Poikiloderma of Civatte
0.003 0.695 0.301
L57.2 Cutis rhomboidalis nuchae
0.003 0.695 0.301
L57.1 Actinic reticuloid
0.003 0.695 0.301
E24.8 Other Cushing's syndrome
0.302 0.698 0.000
E15 Nondiabetic hypoglycaemic coma
0.298 0.702 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.294 0.706 0.000
L20.8 Other atopic dermatitis
0.001 0.707 0.292
E28 Ovarian dysfunction
0.292 0.708 0.000
L21.8 Other seborrhoeic dermatitis
0.001 0.710 0.289
L21.1 Seborrhoeic infantile dermatitis
0.001 0.710 0.289
L21.0 Seborrhoea capitis
0.001 0.710 0.289
L60.2 Onychogryphosis
0.000 0.712 0.288
L51 Erythema multiforme
0.010 0.712 0.278
E10.8 With unspecified complications
0.288 0.712 0.000
E16.1 Other hypoglycaemia
0.287 0.713 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.